We are live on ! Find out more
CIA

Capital Impact Advisors Portfolio holdings

AUM $247M
1-Year Est. Return 31.15%
This Fund
S&P 500
This Quarter Est. Return
-9.19%
1 Year Est. Return
+31.15%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$138M
AUM Growth
-$7.43M
Cap. Flow
+$9.14M
Cap. Flow %
6.65%
Top 10 Hldgs %
13.44%
Holding
199
New
102
Increased
30
Reduced
53
Closed
12

Top Buys

Rank Stock Value
1
OMCL icon
Omnicell
OMCL
+$2.11M
2
NVDA icon
NVIDIA
NVDA
+$1.99M
3
UPST icon
Upstart Holdings
UPST
+$1.33M
4
CLH icon
Clean Harbors
CLH
+$1.13M
5
SSTK icon
Shutterstock
SSTK
+$1.07M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$4.88M
2
MSFT icon
Microsoft
MSFT
+$4.2M
3
AMZN icon
Amazon
AMZN
+$3.87M
4
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$3.58M
5
SNPS icon
Synopsys
SNPS
+$2.45M

Sector Composition

Rank Sector Weight
1 Technology 29.61%
2 Healthcare 24.32%
3 Consumer Discretionary 11.69%
4 Industrials 9.16%
5 Financials 8.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WWE
51
DELISTED
World Wrestling Entertainment
WWE
$919K 0.67%
+14,719
New +$812K
NSP icon
52
Insperity
NSP
$1.93B
$912K 0.66%
9,077
-10,767
-54% -$1.07M
NSSC icon
53
Napco Security Technologies
NSSC
$1.32B
$900K 0.65%
+43,864
New +$911K
BOX icon
54
Box
BOX
$4.37B
$892K 0.65%
30,690
+7,550
+33% +$199K
SAH icon
55
Sonic Automotive
SAH
$2.9B
$884K 0.64%
+20,803
New +$1.02M
MXL icon
56
MaxLinear
MXL
$6.06B
$877K 0.64%
15,034
+5,411
+56% +$329K
REGN icon
57
Regeneron Pharmaceuticals
REGN
$78.5B
$874K 0.64%
1,251
-701
-36% -$443K
TENB icon
58
Tenable Holdings
TENB
$3.6B
$869K 0.63%
+15,033
New +$777K
TSLA icon
59
Tesla
TSLA
$1.23T
$859K 0.62%
+2,391
New +$745K
QCOM icon
60
Qualcomm
QCOM
$155B
$858K 0.62%
+5,614
New +$942K
WIRE
61
DELISTED
Encore Wire Corp
WIRE
$850K 0.62%
7,451
+3,032
+69% +$364K
RMD icon
62
ResMed
RMD
$30.6B
$847K 0.62%
3,492
-1,956
-36% -$473K
SUPN icon
63
Supernus Pharmaceuticals
SUPN
$2.59B
$837K 0.61%
+25,910
New +$794K
TDOC icon
64
Teladoc Health
TDOC
$1.22B
$835K 0.61%
+11,580
New +$834K
CPRX
65
DELISTED
Catalyst Pharmaceutical
CPRX
$823K 0.6%
+99,322
New +$702K
SF
66
Stifel
SF
$12.6B
$817K 0.59%
18,047
-41,566
-70% -$2M
EB
67
DELISTED
Eventbrite
EB
$801K 0.58%
54,207
+5,157
+11% +$76.5K
MD icon
68
Pediatrix Medical
MD
$2.18B
$794K 0.58%
+33,808
New +$828K
MPWR icon
69
Monolithic Power Systems
MPWR
$70.1B
$792K 0.58%
+1,630
New +$710K
VICR icon
70
Vicor
VICR
$9.56B
$790K 0.57%
+11,194
New +$1.01M
EGRX
71
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$788K 0.57%
15,918
-3,358
-17% -$161K
CSTL icon
72
Castle Biosciences
CSTL
$855M
$786K 0.57%
17,531
-6,898
-28% -$285K
FNKO icon
73
Funko
FNKO
$326M
$764K 0.56%
44,309
+17,555
+66% +$307K
DHR icon
74
Danaher
DHR
$137B
$761K 0.55%
2,926
-5,092
-64% -$1.27M
GRWG icon
75
GrowGeneration
GRWG
$86.5M
$761K 0.55%
82,605
+59,247
+254% +$534K
1 2
3
4 5

Similar funds

AI
AXS Investments Port Chester, New York $248M AUM 15.95% 1-Year Est. Return
AB
ANB Bank Denver, Colorado $247M AUM 19.59% 1-Year Est. Return
PWS
Peloton Wealth Strategists Indianapolis, Indiana $247M AUM 13.57% 1-Year Est. Return
BFM
Blacksheep Fund Management Co. Dublin, Ireland $247M AUM 8.75% 1-Year Est. Return
IFPG
Intrepid Financial Planning Group Carmel, Indiana $248M AUM 19.02% 1-Year Est. Return
SCM
Segra Capital Management Palm Beach, Florida $248M AUM 65.61% 1-Year Est. Return
GWS
Greykasell Wealth Strategies Danville, California $248M AUM 22.08% 1-Year Est. Return
MC
Mount Capital London, United Kingdom $248M AUM 4.81% 1-Year Est. Return

Capital Impact Advisors's Q1 2022 Portfolio in Review

As of Q1 2022, Capital Impact Advisors held 199 positions worth $138M, down 5.1% from $145M the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Capital Impact Advisors deployed $9.14M of net new capital in Q1 2022, opening 102 new positions and adding to 30 existing holdings. Its largest new stake was Omnicell: 14,606 shares worth $1.89M.

By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 24% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Apple, an estimated $4.88M trimmed.

  • Capital Impact Advisors's largest Q1 2022 buy was Omnicell: 14,606 shares worth $1.89M.
  • Capital Impact Advisors added most to e.l.f. Beauty in Q1 2022, an estimated $853K increase.
  • Capital Impact Advisors's biggest Q1 2022 reduction was Apple, cutting an estimated $4.88M.
  • Capital Impact Advisors fully exited Medpace in Q1 2022, selling an estimated $1.89M.
  • Capital Impact Advisors's ten largest holdings make up 13% of its $138M portfolio in Q1 2022.
  • Capital Impact Advisors opened 102 new positions and closed 12 in Q1 2022.
  • Capital Impact Advisors's portfolio value fell 5.1% quarter-over-quarter to $138M.

Based on Capital Impact Advisors's 13F filing for Q1 2022, filed 16 May 2022.